LINDSEY GROVES: Open Payments
NPI 1932425915 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 33 payments from 10 companies in 2025. Trend: 2023 $276 · 2024 $358 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $174 |
| Averitas Pharma Inc. | 8 | $129 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $110 |
| Medtronic, Inc. | 1 | $57 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Valinor Pharma, LLC | 2 | $34 |
| Globus Medical, Inc. | 1 | $26 |
| Bioventus LLC | 1 | $17 |
| Tonix Medicines, Inc. | 1 | $14 |
Products named: BOTOX, QUTENZA, RELISTOR, INCEPTIV, JOURNAVX, Belbuca, MOVANTIK, Senza.
Industry payments across OK — which companies pay providers there.
